Latest Cash Runway News

Aguia Resources reported a challenging quarter with significant cash outflows but bolstered its position through a $5.3 million capital raise and a new bank loan for its phosphate project.

Thrive Tribe Technologies reported a $451,000 net operating cash outflow in Q1 FY26 but bolstered its cash reserves to $589,000 through over $1 million in equity placements. The company progressed its Thrive Tribe Home Base initiative and expanded its digital business units while managing a limited cash runway.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Cynata Therapeutics is on track to deliver key clinical trial results in mid-2026 while maintaining a solid cash runway supported by an imminent R&D tax rebate and equity facility.

Heavy Minerals Limited is finalising its Port Gregory Garnet Project Pre-Feasibility Study with a report due in November 2025, while advancing a promising industrial minerals project towards a binding agreement expected this quarter.

Eagle Mountain Mining continues to push forward with its Arizona copper-gold projects while negotiating loan restructuring, maintaining a cautious cash position of $566,000 at quarter-end.

RocketBoots Limited has secured new trial contracts worth $208,000 with major retail banks in Australia and Mexico, while expanding its international sales pipeline and appointing a seasoned CFO/COO to support growth.

European Metals Holdings has advanced its Cinovec Lithium Project with a new preliminary mining permit and secured funding to complete its Definitive Feasibility Study, reinforcing its position in Europe's critical raw materials landscape.

Northern Minerals Limited reported a net operating cash outflow of AUD 6.61 million for Q3 2025, ending the quarter with AUD 17.48 million in cash and equivalents and a solid financing facility.

KALiNA Power advances its Alberta AI data centre power projects with a significant CAD 18 million transfer of assigned megawatts and engages bankers to fund development capital.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.